The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 17, 2021

Filed:

Jul. 28, 2017
Applicants:

The Regents of the University of California, Oakland, CA (US);

Gunma University, Gunma, JP;

Kazuya Miyashita, Gunma, JP;

Inventors:

Kazuya Miyashita, Gunma, JP;

Stephen G. Young, Los Angeles, CA (US);

Anne P. Beigneux, Los Angeles, CA (US);

Loren G. Fong, Los Angeles, CA (US);

Katsuyuki Nakajima, Gunma, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/536 (2006.01); A61K 31/557 (2006.01); G01N 33/68 (2006.01); G01N 33/92 (2006.01); C07K 16/28 (2006.01); A61P 3/06 (2006.01); C12N 15/63 (2006.01); G01N 33/577 (2006.01); A61M 1/34 (2006.01);
U.S. Cl.
CPC ...
A61K 31/557 (2013.01); A61P 3/06 (2018.01); C07K 16/28 (2013.01); C12N 15/63 (2013.01); G01N 33/577 (2013.01); G01N 33/6854 (2013.01); G01N 33/92 (2013.01); A61M 1/3496 (2013.01); C07K 2317/21 (2013.01); C07K 2317/76 (2013.01); G01N 2800/044 (2013.01);
Abstract

This application describes novel therapeutic strategies for treating patients with hypertriglyceridemia and/or chylomicronemia based on the presence of GPIHBP1 autoantibodies. It was unexpectedly found that autoantibodies to GPIHBP1, a GPI anchored protein of capillary endothelial cells that shuttles lipoprotein lipase to its site of action in the capillary lumen, were found to be present in patients with hypertriglyceridemia, and that the autoantibodies blocked the binding of lipoprotein lipase (LPL) to GPIHBP1. Patients having hypertriglyceridemia and/or chylomicronemia and also having GPIHBP1 autoantibodies may be treated with a therapeutically effective amount of an immunosuppressive treatment and/or GPIHBP1 activator.


Find Patent Forward Citations

Miyashita, Kazuya. (2021). Methods and compositions for treating hypertriglyceridemia (U.S. Patent No. 11090310). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11090310

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…